Fadri-Moskwik Maria, Zhou Qing, Chai Weihang
Section of Medical Sciences and School of Molecular Biosciences, Washington State University, USA.
J Mol Genet Med. 2013 Dec;7(4). doi: 10.4172/1747-0862.1000091. Epub 2013 Dec 9.
Telomeres are areas of heterochromatin composed of TTAGGG repeats located at the ends of linear chromosomes. They play a critical role in keeping genome stable and preventing premature aging diseases and the development of cancer. Characterizing mechanisms of telomere maintenance and understanding how their deregulation contributes to human diseases are therefore important for developing novel therapies. A key mechanism driving telomere maintenance and replicative immortality in cancer cells is telomere elongation by telomerase, and many emerging potential telomere-based therapies have focused on targeting telomerase components. By contrast, recent studies on telomere maintenance mechanism suggest that disrupting telomere stability by interfering with alternative mechanisms of telomere synthesis or protection may also yield new strategies for the treatment of cancer. This review will focus on emerging regulators of telomere synthesis or maintenance, such as G4 telomeric DNA, the CST complex, the t-loop, and shelterins, and discuss their potential as targets for anti-cancer chemotherapeutic intervention in the future.
端粒是位于线性染色体末端的由TTAGGG重复序列组成的异染色质区域。它们在维持基因组稳定、预防早衰疾病和癌症发展方面发挥着关键作用。因此,表征端粒维持机制并了解其失调如何导致人类疾病对于开发新疗法至关重要。驱动癌细胞中端粒维持和复制永生的一个关键机制是端粒酶介导的端粒延长,许多新兴的潜在基于端粒的疗法都集中在靶向端粒酶成分上。相比之下,最近关于端粒维持机制的研究表明,通过干扰端粒合成或保护的替代机制来破坏端粒稳定性也可能产生治疗癌症的新策略。本综述将重点关注端粒合成或维持的新兴调节因子,如G4端粒DNA、CST复合物、t环和端粒保护蛋白,并讨论它们未来作为抗癌化疗干预靶点的潜力。